MedCerts and New Hope Training Programs Forge Partnership to Empower Students and Advance Diversity in the Healthcare Workforce
18 déc. 2024 09h00 HE
|
MedCerts
FAYETTEVILLE, Ga., Dec. 18, 2024 (GLOBE NEWSWIRE) -- MedCerts and New Hope Training Programs LLC are excited to announce an impactful partnership to make healthcare education more accessible,...
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
04 déc. 2024 09h10 HE
|
EDAP TMS S.A.
HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatmentsPositive study results are expected to drive...
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
27 nov. 2024 07h00 HE
|
EDAP TMS S.A.
LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is...
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
22 nov. 2024 08h00 HE
|
EDAP TMS S.A.
Early feasibility work demonstrates Focal One system’s ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in...
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
19 nov. 2024 08h00 HE
|
EDAP TMS S.A.
Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS...
EDAP Reports Third Quarter 2024 Financial Results
07 nov. 2024 07h00 HE
|
EDAP TMS S.A.
Reported Q3 worldwide revenue of EUR 13.1 million (USD 14.4 million), increasing 11.6% over Q3 2023Reported Q3 worldwide HIFU revenue of EUR 4.5 million (USD 4.9 million), increasing 48.2%...
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
06 nov. 2024 08h00 HE
|
EDAP TMS S.A.
LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to...
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
24 oct. 2024 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
01 oct. 2024 07h00 HE
|
EDAP TMS S.A.
LYON, France, October 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II...
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
19 sept. 2024 08h00 HE
|
EDAP TMS S.A.
First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of MedicineFDA-cleared Unfold AI enables urologists to...